Clinical Trial Update: Vaccine Therapy in Treating Patients Who Are Undergoing Surgery for Ductal Carcinoma In Situ of the Breast [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating a vaccine therapy for patients undergoing surgery for ductal carcinoma in situ of the breast has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ductal Carcinoma in Situ

Drugs mentioned

• Vaccine therapy

Snippet

Sponsor: Abramson Cancer Center at Penn Medicine | Conditions: Breast Cancer | Phase 1 | Status: COMPLETED